术中使用小剂量右美托咪定对乳腺癌手术患者预后的影响
|
|
杨笑萱, 朱珊, 钱程, 储晓英
|
Effect of intraoperative use of low-dose dexmedetomidine on the prognosis of patients undergoing breast cancer surgery
|
|
YANG Xiaoxuan, ZHU Shan, QIAN Cheng, CHU Xiaoying
|
|
表2 倾向性评分匹配后2组患者基线特征及围术期资料比较
|
Tab 2 Comparison of baseline characteristics and perioperative data between the two groups after propensity score matching
|
|
| Item | DEX group (n=239) | Control group (n=239) | P value |
|---|
| Age/year | 54.3±0.8 | 52.9±0.8 | 0.212 | | BMI/(kg·m-2) | 23.1±0.2 | 23.0±0.2 | 0.681 | | Chemotherapy/n(%) | 168 (70.3) | 161 (67.4) | 0.548 | | Radiotherapy/n(%) | 119 (49.8) | 108 (45.2) | 0.357 | | Hormonal therapy/n(%) | 116 (48.5) | 109 (45.6) | 0.582 | | ER+/n(%) | 125 (52.3) | 141 (59.0) | 0.174 | | PR+/n(%) | 158 (66.1) | 140 (58.6) | 0.113 | | HER2+/n(%) | 60 (25.1) | 58 (24.3) | 0.916 | | Ki67/n(%) | 129 (54.0) | 141 (59.0) | 0.308 | | ASA classification/n(%) | | | 0.082 | | Ⅰ | 109 (45.6) | 129 (54.0) | | | Ⅱ | 130 (54.4) | 110 (46.0) | | | TMN stage/n(%) | | | 0.531 | | 0 | 24 (9.9) | 21 (8.5) | | | Ⅰ | 103 (43.3) | 100 (41.9) | | | ⅡA | 75 (31.2) | 79 (33.1) | | | ⅡB | 10 (4.3) | 12 (5.1) | | | Ⅲ | 27 (11.1) | 27 (11.4) | | | Type of surgery/n(%) | | | 0.176 | | Breast-conserving surgery | 6 (25.8) | 58 (24.3) | | | Mastectomy | 177 (74.2) | 181 (75.7) | | | Duration of anesthesia/min | 64.6±1.3 | 62.2±1.0 | 0.162 | | Remifentanil/μg | 680.5±20.7 | 704.7±21.6 | 0.416 | | Sufentanyl/μg | 34.0±0.7 | 34.2±0.7 | 0.781 | | Propofol/mg | 141.9±1.5 | 138.2±1.4 | 0.073 | | Cisatracurium/mg | 19.4±0.3 | 19.1±0.3 | 0.367 | | Inhalable anesthetic/n(%) | | | 0.564 | | Sevoflurane | 83 (34.8) | 76 (32.1) | | | Desflurane | 156 (65.2) | 163 (67.9) | | | VAS score when leaving PACU | 0.6±0.0 | 0.7±0.1 | 0.125 | | Propensity score | 0.29±0.07 | 0.30±0.06 | 0.331 |
|
|
|